<?xml version="1.0" encoding="UTF-8"?>
<p>The International Working Group (IWG) 1999 and 2007 criteria were used to define responses after four and six cycles, respectively. [
 <sup>18</sup>F]fluorodeoxyglucose (FDG)-positron emission tomography (FDG-PET) responses were evaluated in each center with the five-point scale, visual method of Deauville.
 <sup>
  <xref rid="b17-1040138" ref-type="bibr">17</xref>
 </sup> Hematologic and non-hematologic toxicity was monitored continuously during treatment and at follow-up visits and graded according to the National Cancer Institute criteria (Common Terminology Criteria for Adverse Events, version 3.0) (see the 
 <italic>Online Supplementary Methods</italic> for details).
</p>
